Abiopharma

🔍 Duda Kenneth (Director)

Company: Arista Networks, Inc. (ANET)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 13,334 shares of Common Stock at $15.2769 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,310.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,999 shares of Common Stock at $14.1463 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 30,309.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,197 shares of Common Stock at $184.3297 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,112.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,750 shares of Common Stock at $185.1821 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,362.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 6,568 shares of Common Stock at $186.1257 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,794.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 818 shares of Common Stock at $186.9698 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,976.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 3,875 shares of Common Stock at $184.3297 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,027,293.00 | transaction_form_type: 4 | Footnotes: F6, F2, F7
• Sold 5,308 shares of Common Stock at $185.1821 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,021,985.00 | transaction_form_type: 4 | Footnotes: F6, F3, F7
• Sold 6,063 shares of Common Stock at $186.1257 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,015,922.00 | transaction_form_type: 4 | Footnotes: F6, F4, F7
• Sold 754 shares of Common Stock at $186.9698 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,015,168.00 | transaction_form_type: 4 | Footnotes: F6, F5, F7
• Sold 2,422 shares of Common Stock at $184.3297 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 459,978.00 | transaction_form_type: 4 | Footnotes: F8, F2, F9
• Sold 3,317 shares of Common Stock at $185.1821 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 456,661.00 | transaction_form_type: 4 | Footnotes: F8, F3, F9
• Sold 3,789 shares of Common Stock at $186.1257 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 452,872.00 | transaction_form_type: 4 | Footnotes: F8, F4, F9
• Sold 472 shares of Common Stock at $186.9698 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 452,400.00 | transaction_form_type: 4 | Footnotes: F8, F5, F9
• Acquired 3,880 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 110,770.00 | transaction_form_type: 4 | Footnotes: F10, F11
• Acquired 4,148 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 114,918.00 | transaction_form_type: 4 | Footnotes: F10, F11
• Acquired 1,832 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 116,750.00 | transaction_form_type: 4 | Footnotes: F10, F11
• Acquired 19,816 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 136,566.00 | transaction_form_type: 4 | Footnotes: F10, F11
• Acquired 1,350 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 137,916.00 | transaction_form_type: 4 | Footnotes: F10, F11
• Sold 15,541 shares of Common Stock at $186.45 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 122,375.00 | transaction_form_type: 4 | Footnotes: F12, F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By GRAT JD | shares_owned_after: 757,755.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By GRAT KD | shares_owned_after: 756,272.00 | Footnotes: F14
• Sold 3,999 shares of Non-Qualified Stock Option (right to buy) at $14.1463 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2029-02-07 | equity_swap_involved: 0 | shares_owned_after: 156,001.00 | transaction_form_type: 4 | Footnotes: F1, F15
• Sold 13,334 shares of Non-Qualified Stock Option (right to buy) at $15.2769 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2028-11-08 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F16
• Sold 1,350 shares of Restricted Stock Unit - 17 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,550.00 | transaction_form_type: 4 | Footnotes: F10, F17, F17
• Sold 4,148 shares of Restricted Stock Unit-11 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,736.00 | transaction_form_type: 4 | Footnotes: F10, F18, F18
• Sold 4,148 shares of Restricted Stock Unit-11 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,588.00 | transaction_form_type: 4 | Footnotes: F10, F18, F18
• Sold 1,832 shares of Restricted Stock Unit-13 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,516.00 | transaction_form_type: 4 | Footnotes: F10, F19, F19
• Sold 19,816 shares of Restricted Stock Unit-14 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 317,056.00 | transaction_form_type: 4 | Footnotes: F10, F20, F20
• Sold 3,880 shares of Restricted Stock Unit-8 (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,884.00 | transaction_form_type: 4 | Footnotes: F10, F21, F21

Footnotes:

• F1: The exercise and/or sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 11, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.72 to $184.7176, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.72 to $185.719, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.7311 to $186.7213, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.7331 to $187.16, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person for the benefit of the reporting person's children on March 11, 2026.
• F7: These shares are held in a trust for the benefit of a Child of the reporting person for which the reporting person serves as co-trustee. The reporting person shares voting and investment control over the shares but disclaims beneficial ownership of the shares.
• F8: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2026 by the reporting person's 501(c) Foundation, for which the reporting person and his spouse serve as co-trustee.
• F9: These shares are held by a 501(c) Foundation for which the reporting person and his spouse serve as co-trustee.
• F10: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting.
• F11: These shares are held by a family trust for which the reporting person is co-trustee.
• F12: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
• F13: Reporting person's spouse is the trustee of the Jennifer Duda Annuity Trusts.
• F14: Reporting person is the trustee of the Kenneth Duda Annuity Trusts.
• F15: 1/48th of the shares subject to the option shall vest and become exercisable on December 1, 2020 and 1/48th of the shares subject to the option shall continue to vest each month thereafter.
• F16: 1/48th of the shares subject to the option shall vest and become exercisable on December 1, 2020 and 1/48th of the shares subject to the option shall continue to vest each month thereafter.
• F17: Six and one-quarter percent (6.25%) of the restricted stock units awarded vested on February 20, 2026 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, and November 20 of each year.
• F18: Six and one-quarter percent (6.25%) of the restricted stock units awarded vested on on February 20, 2024 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, and November 20 of each year.
• F19: Six and one-quarter percent (6.25%) of the restricted stock units awarded vested on February 20, 2025 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, and November 20 of each year.
• F20: Five percent (5%) of the restricted stock awarded vested on November 20, 2025 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, and November 20 of each year.
• F21: Six and one-quarter percent (6.25%) of the restricted stock units awarded vested on February 20, 2023 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, and November 20 of each year.